| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 23, 2025 | DXCM Dexcom Inc | Brown Michael Jon72 | EVP, Chief Legal Officer | Sell | 10,000 | $84.28 | $842,849.00 | -9.5% | -4.6% | -14.7% | |
| May 23, 2025 | IRIX Iridex Corp | Dizon Romeo R61 | Chief Financial Officer | Buy | 100 | $1.00 | $100.00 | +0.8% | +23.5% | +3.1% | |
| May 23, 2025 | AVTR Avantor, Inc. | Summe Gregory L | Director | Buy | 30,000 | $12.50 | $375,000.00 | +42.9% | -1.0% | -36.0% | |
| May 23, 2025 | EMBC Embecta Corp. | Melcher David F | Director | Buy | 10,000 | $10.60 | $105,995.00 | +13.0% | +29.1% | -69.0% | |
| May 23, 2025 | LAB Standard Biotools Inc. | Kim Hanjoon Alex | Chief Financial Officer | Sell | 1,428 | $0.94 | $1,343.75 | -0.2% | +30.2% | +11.8% | |
| May 23, 2025 | ICUI Icu Medical Inc/de | Voigtlander Christian B.64 | Chief Operating Officer | Sell | 9,918 | $130.02 | $1,289,502.16 | -51.9% | -5.6% | +3.3% | |
| May 23, 2025 | TMDX Transmedics Group, Inc. | Weill David63 | Director | Sell | 732 | $123.88 | $90,680.16 | -5.7% | -4.4% | -44.5% | |
| May 22, 2025 | LAB Standard Biotools Inc. | Kim Hanjoon Alex | Chief Financial Officer | Sell | 1,355 | $1.00 | $1,357.71 | -0.1% | +28.9% | +7.9% | |
| May 22, 2025 | LAB Standard Biotools Inc. | Egholm Michael | President &CEO | Sell | 5,116 | $1.00 | $5,126.23 | -0.2% | +28.9% | +7.9% | |
| May 22, 2025 | IRIX Iridex Corp | Dizon Romeo R61 | Chief Financial Officer | Buy | 200 | $1.00 | $200.98 | +0.9% | +29.3% | - | |
| May 22, 2025 | EW Edwards Lifesciences Corp | Chopra Daveen59 | Cvp, Tmtt | Sell | 1,500 | $75.08 | $112,612.50 | -4.3% | +8.8% | +14.7% | |
| May 22, 2025 | WRBY Warby Parker Inc. | Moon Youngme E65 | Director | Sell | 33,073 | $19.90 | $658,152.70 | -38.0% | +31.7% | +24.4% | |
| May 22, 2025 | BLCO Bausch & Lomb Corp | Saunders Brent L51 | CEO And Chairman Of The Board | Buy | 22,000 | $11.28 | $248,072.00 | +3.2% | +29.2% | +41.5% | |
| May 22, 2025 | AVTR Avantor, Inc. | Summe Gregory L | Director | Buy | 20,000 | $12.65 | $253,000.00 | +40.0% | +0.2% | -36.9% | |
| May 22, 2025 | ATR Aptargroup, Inc. | Gong Xiangwei57 | President, Asia | Sell | 7,000 | $156.49 | $1,095,446.10 | -40.5% | -9.9% | -25.8% | |
| May 22, 2025 | RMD Resmed Inc | Sandercock Brett62 | Chief Financial Officer | Sell | 3,644 | $244.59 | $891,285.96 | -4.1% | +17.7% | -15.3% | |
| May 22, 2025 | AXGN Axogen, Inc. | Tyndall Joseph A. | Director | Sell | 20,062 | $11.20 | $224,694.40 | -34.6% | +42.2% | +273.9% | |
| May 22, 2025 | LAB Standard Biotools Inc. | MacKay Sean | SVP &Chief Business Officer | Sell | 25,374 | $1.02 | $25,784.21 | -1.4% | +28.9% | +7.9% | |
| May 22, 2025 | NMTC Neuroone Medical Technologies Corp | Christianson Mark67 | Business Development Director | Sell | 8,981 | $0.62 | $5,595.54 | -1.6% | +22.0% | - | |
| May 22, 2025 | LUCD Lucid Diagnostics Inc. | Matheis Dennis | Director | Buy | 350,000 | $1.31 | $457,606.58 | +69.5% | -22.6% | - | |
| May 21, 2025 | LFWD Lifeward Ltd. | Jasinski Lawrence J62 | Chief Executive Officer | Sell | 1,909 | $1.26 | $2,405.34 | -1.9% | -48.4% | -55.6% | |
| May 21, 2025 | IDXX Idexx Laboratories Inc /de | Szostak M Anne | Director | Sell | 2,306 | $512.97 | $1,182,916.79 | -52.8% | +27.1% | +10.4% | |
| May 21, 2025 | ZOMDF Zomedica Corp. | Blair Anthony K | COO | Buy | 100,000 | $0.05 | $4,963.75 | +5.4% | - | - | |
| May 21, 2025 | AORT Artivion, Inc. | Holloway Jean F49 | SVP, General Counsel | Sell | 9,926 | $29.00 | $287,854.00 | -5.0% | +47.2% | -20.2% | |
| May 21, 2025 | BSX Boston Scientific Corp | Brown Vance R | SVP, GC And Corp. Secretary | Sell | 4,826 | $106.42 | $513,582.92 | -13.3% | -0.9% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.